Adaptimmune Therapeutics plc (NASDAQ:ADAP) Q4 2024 Earnings Call Transcript March 20, 2025
Operator: Hello, and welcome to the Adaptimmune’s Q4 and Full Year 2024 Business Update Conference Call. As a reminder, all participants are in a listen-only mode. The conference is being recorded. After the presentation, there will be an opportunity to ask questions [Operator Instructions]. I would now like to turn the floor over to Juli Miller, Investor Relations for Adaptimmune. Juli, please go...
